Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report
Since nucleoside-modified mRNA vaccines strongly activate T follicular helper cells, it is important to explore the possible impact of approved SARS-CoV-2 mRNA vaccines on neoplasms affecting this cell type. Herein, we report and discuss unexpected rapid progression of lymphomatous lesions after adm...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2021-11-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2021.798095/full |
| _version_ | 1818845956432461824 |
|---|---|
| author | Serge Goldman Dominique Bron Thomas Tousseyn Irina Vierasu Laurent Dewispelaere Pierre Heimann Elie Cogan Michel Goldman |
| author_facet | Serge Goldman Dominique Bron Thomas Tousseyn Irina Vierasu Laurent Dewispelaere Pierre Heimann Elie Cogan Michel Goldman |
| author_sort | Serge Goldman |
| collection | DOAJ |
| description | Since nucleoside-modified mRNA vaccines strongly activate T follicular helper cells, it is important to explore the possible impact of approved SARS-CoV-2 mRNA vaccines on neoplasms affecting this cell type. Herein, we report and discuss unexpected rapid progression of lymphomatous lesions after administration of a BNT162b2 mRNA vaccine booster in a man recently diagnosed with AITL. |
| first_indexed | 2024-12-19T05:37:54Z |
| format | Article |
| id | doaj.art-203b9a84312a421abc0475ff22e44518 |
| institution | Directory Open Access Journal |
| issn | 2296-858X |
| language | English |
| last_indexed | 2024-12-19T05:37:54Z |
| publishDate | 2021-11-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Medicine |
| spelling | doaj.art-203b9a84312a421abc0475ff22e445182022-12-21T20:34:04ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2021-11-01810.3389/fmed.2021.798095798095Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case ReportSerge Goldman0Dominique Bron1Thomas Tousseyn2Irina Vierasu3Laurent Dewispelaere4Pierre Heimann5Elie Cogan6Michel Goldman7Department of Nuclear Medicine, Erasme Hospital, Université Libre de Bruxelles, Brussels, BelgiumDepartment of Hematology, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, BelgiumDepartment of Pathology, UZ Leuven Hospitals, Leuven, BelgiumDepartment of Nuclear Medicine, Erasme Hospital, Université Libre de Bruxelles, Brussels, BelgiumLaboratory of Hematology, LHUB, Université Libre de Bruxelles, Brussels, BelgiumLaboratory of Hematology, LHUB, Université Libre de Bruxelles, Brussels, BelgiumDepartment of Internal Medicine, CHIREC Hospital, Brussels, BelgiumI3h Institute, Université Libre de Bruxelles, Brussels, BelgiumSince nucleoside-modified mRNA vaccines strongly activate T follicular helper cells, it is important to explore the possible impact of approved SARS-CoV-2 mRNA vaccines on neoplasms affecting this cell type. Herein, we report and discuss unexpected rapid progression of lymphomatous lesions after administration of a BNT162b2 mRNA vaccine booster in a man recently diagnosed with AITL.https://www.frontiersin.org/articles/10.3389/fmed.2021.798095/fullmRNA vaccineT celllymphomaCOVID-19angioimmunoblasticfollicular |
| spellingShingle | Serge Goldman Dominique Bron Thomas Tousseyn Irina Vierasu Laurent Dewispelaere Pierre Heimann Elie Cogan Michel Goldman Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report Frontiers in Medicine mRNA vaccine T cell lymphoma COVID-19 angioimmunoblastic follicular |
| title | Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report |
| title_full | Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report |
| title_fullStr | Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report |
| title_full_unstemmed | Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report |
| title_short | Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report |
| title_sort | rapid progression of angioimmunoblastic t cell lymphoma following bnt162b2 mrna vaccine booster shot a case report |
| topic | mRNA vaccine T cell lymphoma COVID-19 angioimmunoblastic follicular |
| url | https://www.frontiersin.org/articles/10.3389/fmed.2021.798095/full |
| work_keys_str_mv | AT sergegoldman rapidprogressionofangioimmunoblastictcelllymphomafollowingbnt162b2mrnavaccineboostershotacasereport AT dominiquebron rapidprogressionofangioimmunoblastictcelllymphomafollowingbnt162b2mrnavaccineboostershotacasereport AT thomastousseyn rapidprogressionofangioimmunoblastictcelllymphomafollowingbnt162b2mrnavaccineboostershotacasereport AT irinavierasu rapidprogressionofangioimmunoblastictcelllymphomafollowingbnt162b2mrnavaccineboostershotacasereport AT laurentdewispelaere rapidprogressionofangioimmunoblastictcelllymphomafollowingbnt162b2mrnavaccineboostershotacasereport AT pierreheimann rapidprogressionofangioimmunoblastictcelllymphomafollowingbnt162b2mrnavaccineboostershotacasereport AT eliecogan rapidprogressionofangioimmunoblastictcelllymphomafollowingbnt162b2mrnavaccineboostershotacasereport AT michelgoldman rapidprogressionofangioimmunoblastictcelllymphomafollowingbnt162b2mrnavaccineboostershotacasereport |